Advertisement

More articles from Erratum

You have access
Correction to: “Imperatorin Is a Mechanism-Based Inactivator of CYP2B6”
Drug Metabolism and Disposition April 2015, 43 (4) 570; DOI: https://doi.org/10.1124/dmd.115.060558err
You have access
Correction to “Evaluation of Near Infrared Fluorescent Labeling of Monoclonal Antibodies as a Tool for Tissue Distribution”
Drug Metabolism and Disposition January 2015, 43 (1) 53; DOI: https://doi.org/10.1124/dmd.114.060319err
You have access
Correction to “Drug-Induced Perturbations of the Bile Acid Pool, Cholestasis, and Hepatotoxicity: Mechanistic Considerations Beyond the Direct Inhibition of the Bile Salt Export Pump”
Drug Metabolism and Disposition November 2014, 42 (11) 1978; DOI: https://doi.org/10.1124/dmd.114.054205err
You have access
Correction to “Enhanced Nicotine Metabolism in HIV-1–Positive Smokers Compared with HIV-Negative Smokers: Simultaneous Determination of Nicotine and its Four Metabolites in Their Plasma Using a Simple and Sensitive Electrospray Ionization Liquid Chromatography–Tandem Mass Spectrometry Technique”
Drug Metabolism and Disposition September 2014, 42 (9) 1596-1598; DOI: https://doi.org/10.1124/dmd.114.055186err
You have access
Correction to “The Influence of Sex, Ethnicity, and CYP2B6 Genotype on Bupropion Metabolism as an Index of Hepatic CYP2B6 Activity in Humans”
Drug Metabolism and Disposition July 2014, 42 (7) 1137; DOI: https://doi.org/10.1124/dmd.114.07er14
You have access
Correction to “Human Arylacetamide Deacetylase Is a Principal Enzyme in Flutamide Hydrolysis”
Drug Metabolism and Disposition June 2014, 42 (6) 1066; DOI: https://doi.org/10.1124/dmd.114.06er14
You have access
Correction to “Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s”
Drug Metabolism and Disposition May 2014, 42 (5) 917; DOI: https://doi.org/10.1124/dmd.114.05er14a
You have access
Correction to “Expression of the Orphan Cytosolic Sulfotransferase SULT1C3 in Human Intestine: Characterization of the Transcript Variant and Implications for Function”
Drug Metabolism and Disposition May 2014, 42 (5) 853; DOI: https://doi.org/10.1124/dmd.114.05er14
You have access
Correction to “Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac”
Drug Metabolism and Disposition January 2014, 42 (1) 200; DOI: https://doi.org/10.1124/dmd.113.01er14
You have access
Correction to “Characterization of Human Cytochrome P450s Involved in the Bioactivation of Clozapine”
Drug Metabolism and Disposition April 2013, 41 (4) 932; DOI: https://doi.org/10.1124/dmd.112.04er13

Pages